Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Drevets

Showing results (121-130 of 337) with videos related to

Pageof 34
Sort By:
The International Journal of Neuropsychopharmacology|May 22, 2016
The Effect of Mineralocorticoid and Glucocorticoid Receptor Antagonism on Autobiographical Memory Recall and Amygdala Response to Implicit Emotional StimuliKymberly D Young, Sheldon H Preskorn, Teresa Victor, et al.
Plos One|February 14, 2014
Real-time FMRI neurofeedback training of amygdala activity in patients with major depressive disorderKymberly D Young, Vadim Zotev, Raquel Phillips, et al.
Human Brain Mapping|June 15, 2012
Keeping the body in mind: insula functional organization and functional connectivity integrate interoceptive, exteroceptive, and emotional awarenessW Kyle Simmons, Jason A Avery, Joel C Barcalow, et al.
Nuclear Medicine and Biology|August 30, 2000
Serotonin type-1A receptor imaging in depressionW C Drevets, E Frank, J C Price, et al.
The American Journal of Managed Care|February 6, 1997
Course of antidepressant treatment with tricyclic versus selective serotonin reuptake inhibitor agents: a comparison in managed care and fee-for-service environmentsK A Fairman, F Teitelbaum, W C Drevets, et al.
Archives of General Psychiatry|February 7, 2007
Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopyGregor Hasler, Jan Willem van der Veen, Toni Tumonis, et al.
The International Journal of Neuropsychopharmacology|July 29, 2021
Efficacy and Safety of Seltorexant as Adjunctive Therapy in Major Depressive Disorder: A Phase 2b, Randomized, Placebo-Controlled, Adaptive Dose-Finding StudyAdam Savitz, Ewa Wajs, Yun Zhang, et al.
Health and Quality of Life Outcomes|May 9, 2023
Assessment of health-related quality of life and health status in patients with treatment-resistant depression treated with esketamine nasal spray plus an oral antidepressantCarol Jamieson, Vanina Popova, Ella Daly, et al.
Neuroscience and Biobehavioral Reviews|October 4, 2015
Translating depression biomarkers for improved targeted therapiesDavid S Bredt, Maura L Furey, Guang Chen, et al.
Psychiatry Research. Neuroimaging|July 2, 2016
Amygdala response to explicit sad face stimuli at baseline predicts antidepressant treatment response to scopolamine in major depressive disorderJoanna Szczepanik, Allison C Nugent, Wayne C Drevets, et al.
Pageof 34

Showing results (121-130 of 337) with videos related to

Sort By:
Pageof 34
The International Journal of Neuropsychopharmacology|May 22, 2016
The Effect of Mineralocorticoid and Glucocorticoid Receptor Antagonism on Autobiographical Memory Recall and Amygdala Response to Implicit Emotional StimuliKymberly D Young, Sheldon H Preskorn, Teresa Victor, et al.
Plos One|February 14, 2014
Real-time FMRI neurofeedback training of amygdala activity in patients with major depressive disorderKymberly D Young, Vadim Zotev, Raquel Phillips, et al.
Human Brain Mapping|June 15, 2012
Keeping the body in mind: insula functional organization and functional connectivity integrate interoceptive, exteroceptive, and emotional awarenessW Kyle Simmons, Jason A Avery, Joel C Barcalow, et al.
Nuclear Medicine and Biology|August 30, 2000
Serotonin type-1A receptor imaging in depressionW C Drevets, E Frank, J C Price, et al.
The American Journal of Managed Care|February 6, 1997
Course of antidepressant treatment with tricyclic versus selective serotonin reuptake inhibitor agents: a comparison in managed care and fee-for-service environmentsK A Fairman, F Teitelbaum, W C Drevets, et al.
Archives of General Psychiatry|February 7, 2007
Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopyGregor Hasler, Jan Willem van der Veen, Toni Tumonis, et al.
The International Journal of Neuropsychopharmacology|July 29, 2021
Efficacy and Safety of Seltorexant as Adjunctive Therapy in Major Depressive Disorder: A Phase 2b, Randomized, Placebo-Controlled, Adaptive Dose-Finding StudyAdam Savitz, Ewa Wajs, Yun Zhang, et al.
Health and Quality of Life Outcomes|May 9, 2023
Assessment of health-related quality of life and health status in patients with treatment-resistant depression treated with esketamine nasal spray plus an oral antidepressantCarol Jamieson, Vanina Popova, Ella Daly, et al.
Neuroscience and Biobehavioral Reviews|October 4, 2015
Translating depression biomarkers for improved targeted therapiesDavid S Bredt, Maura L Furey, Guang Chen, et al.
Psychiatry Research. Neuroimaging|July 2, 2016
Amygdala response to explicit sad face stimuli at baseline predicts antidepressant treatment response to scopolamine in major depressive disorderJoanna Szczepanik, Allison C Nugent, Wayne C Drevets, et al.
Pageof 34